BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22929011)

  • 21. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
    Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells.
    Sirchia SM; Ferguson AT; Sironi E; Subramanyan S; Orlandi R; Sukumar S; Sacchi N
    Oncogene; 2000 Mar; 19(12):1556-63. PubMed ID: 10734315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic silencing of the tumor suppressor klotho in human breast cancer.
    Rubinek T; Shulman M; Israeli S; Bose S; Avraham A; Zundelevich A; Evron E; Gal-Yam EN; Kaufman B; Wolf I
    Breast Cancer Res Treat; 2012 Jun; 133(2):649-57. PubMed ID: 22042362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H; Kim JH; Lee YS; Lee YC
    Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secreted phospholipases A₂are differentially expressed and epigenetically silenced in human breast cancer cells.
    Brglez V; Pucer A; Pungerčar J; Lambeau G; Petan T
    Biochem Biophys Res Commun; 2014 Feb; 445(1):230-5. PubMed ID: 24508801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs.
    Deng G; Kakar S; Okudiara K; Choi E; Sleisenger MH; Kim YS
    Clin Cancer Res; 2009 Mar; 15(5):1519-26. PubMed ID: 19223499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure.
    Woodfield GW; Hitchler MJ; Chen Y; Domann FE; Weigel RJ
    Clin Cancer Res; 2009 Jun; 15(11):3672-9. PubMed ID: 19458056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant DNA methylation but not mutation of CITED4 is associated with alteration of HIF-regulated genes in breast cancer.
    Huang KT; Takano EA; Mikeska T; Byrne DJ; Dobrovic A; Fox SB
    Breast Cancer Res Treat; 2011 Nov; 130(1):319-29. PubMed ID: 21755341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer.
    Verschuur-Maes AH; de Bruin PC; van Diest PJ
    Breast Cancer Res Treat; 2012 Dec; 136(3):705-15. PubMed ID: 23104224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-Aza-2'-deoxycytidine (decitabine) on human breast carcinoma cells.
    Hurtubise A; Momparler RL
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):618-25. PubMed ID: 16783580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21.
    Derks S; Bosch LJ; Niessen HE; Moerkerk PT; van den Bosch SM; Carvalho B; Mongera S; Voncken JW; Meijer GA; de Bruïne AP; Herman JG; van Engeland M
    Carcinogenesis; 2009 Jun; 30(6):1041-8. PubMed ID: 19329758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different involvement of DNA methylation and histone deacetylation in the expression of solute-carrier transporters in 4 colon cancer cell lines.
    Ikehata M; Ueda K; Iwakawa S
    Biol Pharm Bull; 2012; 35(3):301-7. PubMed ID: 22382314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylation of specific CpG sites in the P2 promoter of parathyroid hormone-related protein determines the invasive potential of breast cancer cell lines.
    Tost J; Hamzaoui H; Busato F; Neyret A; Mourah S; Dupont JM; Bouizar Z
    Epigenetics; 2011 Aug; 6(8):1035-46. PubMed ID: 21775817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor binding protein-3 (IGFBP-3) plays a role in the anti-tumorigenic effects of 5-Aza-2'-deoxycytidine (AZA) in breast cancer cells.
    Zeng L; Jarrett C; Brown K; Gillespie KM; Holly JM; Perks CM
    Exp Cell Res; 2013 Aug; 319(14):2282-95. PubMed ID: 23810988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation.
    Li X; Liu J; Zhou R; Huang S; Huang S; Chen XM
    Br J Haematol; 2010 Jan; 148(1):69-79. PubMed ID: 19807731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone deacetylase inhibitors promote the expression of ATP2A3 gene in breast cancer cell lines.
    Contreras-Leal E; Hernández-Oliveras A; Flores-Peredo L; Zarain-Herzberg Á; Santiago-García J
    Mol Carcinog; 2016 Oct; 55(10):1477-85. PubMed ID: 26331238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of the S1P
    Filipenko I; Schwalm S; Reali L; Pfeilschifter J; Fabbro D; Huwiler A; Zangemeister-Wittke U
    Biochim Biophys Acta; 2016 Nov; 1861(11):1840-1851. PubMed ID: 27616330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
    Magdinier F; Wolffe AP
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer.
    Pampalakis G; Sotiropoulou G
    Biol Chem; 2006 Jun; 387(6):773-82. PubMed ID: 16800739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential epigenetic regulation of BDNF and NT-3 genes by trichostatin A and 5-aza-2'-deoxycytidine in Neuro-2a cells.
    Ishimaru N; Fukuchi M; Hirai A; Chiba Y; Tamura T; Takahashi N; Tabuchi A; Tsuda M; Shiraishi M
    Biochem Biophys Res Commun; 2010 Mar; 394(1):173-7. PubMed ID: 20188708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.